World leaders are being pressed to honour a commitment made during the COVID-19 pandemic by finalising a crucial international agreement designed to improve global preparedness for future health crises. Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), and Brazil's President, Luiz Inácio Lula da Silva, issued a joint letter ahead of a G7 summit in France, stressing that 'the next pandemic will not wait for us'.
The urgent appeal coincides with a rapidly escalating Ebola outbreak in the Democratic Republic of Congo (DRC), which has already seen 782 confirmed cases and 181 fatalities. This ongoing crisis underscores the immediate need for a unified global strategy to manage and contain infectious diseases effectively.
The proposed WHO pandemic agreement, first announced in March 2021, aims to establish a framework for how countries share information on potential pandemic-causing pathogens and guarantee equitable access to vaccines, tests, and treatments in return. However, negotiations have stalled, with countries missing a May deadline to agree on a key annexe concerning 'pathogen access and benefit sharing'. Developing nations fear a repeat of the COVID-19 scenario, where wealthier countries secured early access to vital medical supplies, leaving poorer nations behind.
Industry representatives, however, have voiced concerns that mandatory requirements for sharing products could hinder research and development efforts, potentially slowing down the innovation needed to combat new threats. This divergence of views has been a significant hurdle in reaching a consensus, despite the shared memory of overflowing hospitals and immense human suffering during the COVID-19 pandemic, which the WHO estimates claimed up to 20 million lives globally and cost economies over £9.6 trillion.
For the UK, participation in this agreement is vital. A robust international framework would help ensure the timely sharing of critical pathogen data, allowing British scientists and pharmaceutical companies to contribute to and benefit from global research efforts. The Foreign, Commonwealth & Development Office (FCDO) would also rely on such protocols to protect British nationals abroad during future outbreaks, advising on travel and coordinating repatriation efforts. The UK Government has been actively involved in these discussions, with its stance often balancing global health security with national interests and the concerns of its pharmaceutical sector.
Dr Tedros and President Lula emphasised that the annexe is 'the last piece of the puzzle' to fulfil humanity's promise never again to face such a crisis unprepared. They called for 'political will at the highest level', a 'spirit of equity', and 'a sense of urgency' to finalise the agreement, highlighting that the investment in an early outbreak detection system is minimal compared to the potential economic and human cost of another pandemic.
Source: World Health Organisation